271 related articles for article (PubMed ID: 17032898)
1. A stochastic simulation model of U.S. breast cancer mortality trends from 1975 to 2000.
Plevritis SK; Sigal BM; Salzman P; Rosenberg J; Glynn P
J Natl Cancer Inst Monogr; 2006; (36):86-95. PubMed ID: 17032898
[TBL] [Abstract][Full Text] [Related]
2. Impact of adjuvant therapy and mammography on U.S. mortality from 1975 to 2000: comparison of mortality results from the cisnet breast cancer base case analysis.
Cronin KA; Feuer EJ; Clarke LD; Plevritis SK
J Natl Cancer Inst Monogr; 2006; (36):112-21. PubMed ID: 17032901
[TBL] [Abstract][Full Text] [Related]
3. Modeling the impact of treatment and screening on U.S. breast cancer mortality: a Bayesian approach.
Berry DA; Inoue L; Shen Y; Venier J; Cohen D; Bondy M; Theriault R; Munsell MF
J Natl Cancer Inst Monogr; 2006; (36):30-6. PubMed ID: 17032892
[TBL] [Abstract][Full Text] [Related]
4. The MISCAN-Fadia continuous tumor growth model for breast cancer.
Tan SY; van Oortmarssen GJ; de Koning HJ; Boer R; Habbema JD
J Natl Cancer Inst Monogr; 2006; (36):56-65. PubMed ID: 17032895
[TBL] [Abstract][Full Text] [Related]
5. The SPECTRUM population model of the impact of screening and treatment on U.S. breast cancer trends from 1975 to 2000: principles and practice of the model methods.
Mandelblatt J; Schechter CB; Lawrence W; Yi B; Cullen J
J Natl Cancer Inst Monogr; 2006; (36):47-55. PubMed ID: 17032894
[TBL] [Abstract][Full Text] [Related]
6. A stochastic model for predicting the mortality of breast cancer.
Lee S; Zelen M
J Natl Cancer Inst Monogr; 2006; (36):79-86. PubMed ID: 17032897
[TBL] [Abstract][Full Text] [Related]
7. Competing risks to breast cancer mortality.
Rosenberg MA
J Natl Cancer Inst Monogr; 2006; (36):15-9. PubMed ID: 17032889
[TBL] [Abstract][Full Text] [Related]
8. The University of Rochester model of breast cancer detection and survival.
Hanin LG; Miller A; Zorin AV; Yakovlev AY
J Natl Cancer Inst Monogr; 2006; (36):66-78. PubMed ID: 17032896
[TBL] [Abstract][Full Text] [Related]
9. A Molecular Subtype-Specific Stochastic Simulation Model of US Breast Cancer Incidence, Survival, and Mortality Trends from 1975 to 2010.
Munoz DF; Xu C; Plevritis SK
Med Decis Making; 2018 Apr; 38(1_suppl):89S-98S. PubMed ID: 29554473
[TBL] [Abstract][Full Text] [Related]
10. A comparative review of CISNET breast models used to analyze U.S. breast cancer incidence and mortality trends.
Clarke LD; Plevritis SK; Boer R; Cronin KA; Feuer EJ
J Natl Cancer Inst Monogr; 2006; (36):96-105. PubMed ID: 17032899
[TBL] [Abstract][Full Text] [Related]
11. Modeling cancer natural history, epidemiology, and control: reflections on the CISNET breast group experience.
Habbema JD; Schechter CB; Cronin KA; Clarke LD; Feuer EJ
J Natl Cancer Inst Monogr; 2006; (36):122-6. PubMed ID: 17032902
[No Abstract] [Full Text] [Related]
12. Impact of mammography on U.S. breast cancer mortality, 1975-2000: are intermediate outcome measures informative?
Habbema JD; Tan SY; Cronin KA
J Natl Cancer Inst Monogr; 2006; (36):105-11. PubMed ID: 17032900
[TBL] [Abstract][Full Text] [Related]
13. Mammography surveillance and mortality in older breast cancer survivors.
Lash TL; Fox MP; Buist DS; Wei F; Field TS; Frost FJ; Geiger AM; Quinn VP; Yood MU; Silliman RA
J Clin Oncol; 2007 Jul; 25(21):3001-6. PubMed ID: 17548838
[TBL] [Abstract][Full Text] [Related]
14. The Wisconsin Breast Cancer Epidemiology Simulation Model.
Fryback DG; Stout NK; Rosenberg MA; Trentham-Dietz A; Kuruchittham V; Remington PL
J Natl Cancer Inst Monogr; 2006; (36):37-47. PubMed ID: 17032893
[TBL] [Abstract][Full Text] [Related]
15. Geographic association between mammography use and mortality reduction in the US.
Das B; Feuer EJ; Mariotto A
Cancer Causes Control; 2005 Aug; 16(6):691-9. PubMed ID: 16049808
[TBL] [Abstract][Full Text] [Related]
16. Changing patterns in breast cancer incidence trends.
Holford TR; Cronin KA; Mariotto AB; Feuer EJ
J Natl Cancer Inst Monogr; 2006; (36):19-25. PubMed ID: 17032890
[TBL] [Abstract][Full Text] [Related]
17. Trends in area-socioeconomic and race-ethnic disparities in breast cancer incidence, stage at diagnosis, screening, mortality, and survival among women ages 50 years and over (1987-2005).
Harper S; Lynch J; Meersman SC; Breen N; Davis WW; Reichman MC
Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):121-31. PubMed ID: 19124489
[TBL] [Abstract][Full Text] [Related]
18. Breast cancer screening policies in developing countries: a cost-effectiveness analysis for India.
Okonkwo QL; Draisma G; der Kinderen A; Brown ML; de Koning HJ
J Natl Cancer Inst; 2008 Sep; 100(18):1290-300. PubMed ID: 18780864
[TBL] [Abstract][Full Text] [Related]
19. Overall survival and cause-specific mortality of patients with stage T1a,bN0M0 breast carcinoma.
Hanrahan EO; Gonzalez-Angulo AM; Giordano SH; Rouzier R; Broglio KR; Hortobagyi GN; Valero V
J Clin Oncol; 2007 Nov; 25(31):4952-60. PubMed ID: 17971593
[TBL] [Abstract][Full Text] [Related]
20. Improved survival for women with stage I breast cancer in south-east Sweden: a comparison between two time periods before and after increased use of adjuvant systemic therapy.
Johansson P; Fohlin H; Arnesson LG; Dufmats M; Nordenskjöld K; Nordenskjöld B; Stål O;
Acta Oncol; 2009; 48(4):504-13. PubMed ID: 19235568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]